Search results
You searched for:
Found 2,172 results
Sorting options:
Date: 01/01/2026 Location: Other
somthing here
1 Educational activity hour
Professionalism
Culturally safe practice
Ethical practice
Addressing health inequities
Date: 01/01/2026 Location: Other
This outcome improvement activity relates to medicinal cannabis - endometriosis and enables doctors to review and enhance their current practice for patients who may benefit from the use of medicinal cannabis to treat endometriosis. The activity will guide you to compare and measure your management of three patient cases prior to, and after applying evidence-based guidelines to patient cases. Guides, tools and templates are provided as you work through this activity. At the completion of this activity, you are asked to reflect and measure your improved patient management and outline systemic changes you may have implemented into your clinical practice.
8.5 Outcome measurement hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on epilepsy in adults and children. The course studies the symptoms of Epilepsy 101, medicinal cannabis treatment options and modes of transmission. Several ways of application are outlined, as well as different products: artisanal preparations, unapproved products and approved medication of purified CBD. Dravet syndrome (DS) is explained, including treatment options, side effects and efficacy. A section describes Lennoz-Gastautsyndrome (LGS) and reviews research and treatment options including side effects. Tuberous Sclerosis Complex (TSC) symptoms are explained and studies and treatment options are discussed. Other potential applications of CBD are outlined including childhood epilepsy, next generation cannabis-based medicines, biosynthesis of cannabinoids in the plant and anticonvulsant effects.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on complex chronic diseases. Content includes planning the management of complex chronic diseases including poly pharmacy, multiple system disease. It evaluates the challenges of effectively integrating cannabis medicines including liver metabolism considerations and drug interactions. The results of a study into patients with chronic diseases (conditions that last 1 year or more and require ongoing medical attention, long lasting conditions with persistent effects), are included where patients have at least two conditions and were prescribed a minimum of four drugs. When choosing a cannabis product, the preferences of the patient, age and clinical condition are to be considered. The course describes dosing of THC and CBD and minimum/ maximum doses. A case study looks into current medications, past treatments, clinical history, treatment options, progress and life quality.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on endocannabinoid support – advanced techniques for maximising ECS efficiency. The course evaluates clinical endocannabinoid deficiency (CED) and examines options to maximise the efficiency and function of the endocannabinoid system including diet, supplements terpenes and therapies. Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. This course discusses findings that provide a mechanistic scenario for how chronic stress, diet and gut microbiota generate a pathological feed-forward loop that contributes to despair behaviour via the central ECS. Finally, a case study of a patient with a long history of migraine headaches, insomnia and anxiety is described, looking at past treatments and treatment options.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This course looks at the planning of clinical treatment and dosing for conditions with medicinal cannabis. General rules of dosing with cannabis medicines are given noting that doses of cannabis medicines should be administered with consistency and regularity. Minimal doses that are clinically effective should be a principle aim. Patient age and previous cannabis use/ experience must be taken into consideration. Cannabis medications should be titrated slowly and conventional medications reduced as symptoms lessen. Treating of rheumatoid arthritis, neuropathic pain, fibromyalgia, headaches and migraine, multiple sclerosis, Parkinson’s (tremor and dystonia), Chron’s disease and ulcerative colitis, chemotherapy induced nausea and vomiting, anxiety and depression, insomnia, PTSD, epilepsy, ASD, ADHD, OCD and Tourette's, diabetes, hypertension, glaucoma, geriatric/palliative care and complex mental health issues are reviewed in this course.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This Women’s Health course focusses on cognitive and sleep issues in perimenopause and menopause and obstructive sleep apnoea. It then moves to recurrent urinary tract infections after menopause including cystitis and genitourinary syndrome of menopause. The final topic includes comprehensive information on hidradenitis suppurativa (acne inversa). Overviews of each condition, the causes, screening, clinical features, differential diagnoses and management options are presented. Case studies are presented for each focus area. andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
5 Educational activity hours
5 Performance review hours
Professionalism
Ethical practice
5 MOPS (AST - Adult Internal Medicine) hours
Date: 01/01/2026 Location: Other
This clinical audit is designed for medical practitioners to build on the knowledge gained from previous studies of medicinal cannabis for neurological disorders. The audit provides the opportunity to review and analyse previous clinical management of patients with neurological disorders, develop a plan to educate and increase skills and knowledge in this area and implement this plan. Participants will apply their medicinal cannabis learning to treating patients with neurological disorders with medicinal cannabis, demonstrating increased skills and knowledge in their management of patient cases. The audit includes a critical case analysis of each case. This stage will be peer reviewed. This audit together with the Complex Certificate of Medicinal Cannabis courses combine to be the HealthCert Professional Diploma of Medicinal Cannabis.
2 Performance review hours
19.5 Outcome measurement hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This men’s health course focuses on the screening, diagnosis and management of androgen deficiency. Content includes management strategies for patients with this condition and determining whether to refer to a specialist. It explains the hypothalamic-pituitary-testicular axis, adrenal androgens and testosterone action. Androgen deficiency is described as well as the classification and causes of male hypogonadism. The diagnostic approach including signs and symptoms of androgen deficiency are supported by diagrams and clinical images. Functional and late onset hypogonadism management options are outlined including lifestyle measures and the benefits and risks of pharmacology.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
6 MOPS (AST - Adult Internal Medicine) hours
Date: 01/01/2026 Location: Other
This men’s health course focuses on screening for dementia in men within the context of a mental health assessment and diagnosing and managing dementia including knowing when to refer to a specialist. Unit one introduces an overview of male mental health issues and stresses the importance of mental health screening and lists possible disorders and comorbidities. Cognitive decline and depression are discussed including how dementia may be worsened by other psychiatric conditions. The risk factors for dementia and test options to rule out other causes are outlined. Subsyndromal depression and cognitive plasticity are discussed. Multiple contributors, common behaviours and other dementia causes are detailed including Parkinson’s and Lewy body dementia. The approach, diagnosis and monitoring are included. Treatment options are outlined for managing behavioural and psychological symptoms of dementia. It discusses neuropsychiatric symptoms and recognises agitation as one of the challenging behaviours. Dementia management, referral options, screening tools and training complete this course.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
6 MOPS (AST - Adult Internal Medicine) hours